Effect of Polyhexanid (Lavanid) on the incidence of surgical side infections in colorectal surgery
Not Applicable
Completed
- Conditions
- C18C19Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junction
- Registration Number
- DRKS00002698
- Lead Sponsor
- niklinik Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 265
Inclusion Criteria
18 years, colorectal surgery, signed consent form
Exclusion Criteria
Pregnancy, allergy to polyhexanide
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does Polyhexanid utilize to prevent surgical site infections in colorectal surgery?
How does the efficacy of Polyhexanid compare to standard antiseptics in colorectal surgical wound care?
Are there specific biomarkers that predict susceptibility to Polyhexanid in colorectal cancer patients?
What are the potential adverse events associated with Polyhexanid use in colorectal surgery and how are they managed?
What are the current combination therapies involving Polyhexanid for reducing surgical site infections in gastrointestinal malignancies?